FLUDARABINE AND CYCLOPHOSPHAMIDE (FC) VERSUS CYCLOPHOSPHAMIDE, VINCRISTINE AND PREDNISONE (CVP) AS FIRST LINE TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL). SINGLE CENTER EXPERIENCE

被引：0
|
作者：
Ionita, H. [1 ]
Chreveresan, L. [1 ]
Mihaescu, R. [1 ]
Ionita, I. [1 ]
Isac, A. [1 ]
Cheveresan, M. [2 ]
Oros, D. [1 ]
Iordache, M. [1 ]
Musta, I. [1 ]
Basa, N. [1 ]
Delamarian, M. [2 ]
机构：
[1] Univ Med & Farm Timisoara, Timisoara, Romania
[2] Cty Hosp, Dept Hematol, Timisoara, Romania
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1203
引用
收藏
页码：468 / 468
页数：1
相关论文
共 50 条
  • [31] Second-line therapies of patients initially treated with fludarabine and cyclophosphamide or fludarabine, cyclophosphamide and rituximab for chronic lymphocytic leukemia within the CLL8 protocol of the German CLL Study Group
    Cramer, Paula
    Fink, Anna-Maria
    Busch, Raymonde
    Eichhorst, Barbara
    Wendtner, Clemens-Martin
    Pflug, Natali
    Langerbeins, Petra
    Bahlo, Jasmin
    Goede, Valentin
    Schubert, Friederike
    Doehner, Hartmut
    Stilgenbauer, Stephan
    Dreger, Peter
    Kneba, Michael
    Boettcher, Sebastian
    Mayer, Jiri
    Hallek, Michael
    Fischer, Kirsten
    LEUKEMIA & LYMPHOMA, 2013, 54 (08) : 1821 - 1822
  • [32] COST-EFFECTIVENESS OF BENDAMUSTINE VERSUS FLUDARABINE FOR FIRST LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IN COLOMBIA
    Bertwistle, D.
    Munakata, J.
    Wehler, E.
    Leyva, V
    Ariza, J. G.
    Zambrano, C.
    Gonzalez, L.
    VALUE IN HEALTH, 2013, 16 (07) : A413 - A413
  • [33] Second-Line Therapies After Treatment with Fludarabine, Cyclophosphamide, and Rituximab (FCR) or Fludarabine and Cyclophosphamid Alone (FC) for Chronic Lymphocytic Leukemia (CLL) within the CLL8-Protocol of the German CLL Study Group (GCLLSG)
    Cramer, Paula
    Fink, Anna-Maria
    Busch, Raymonde
    Eichhorst, Barbara
    Wendtner, Clemens-Martin
    Pflug, Natali
    Schubert, Friederike
    Doehner, Hartmut
    Rieger, Michael
    Kneba, Michael
    Mayer, Jiri
    Hallek, Michael
    Fischer, Kirsten
    BLOOD, 2011, 118 (21) : 1235 - 1235
  • [34] Cost-effectiveness of rituximab, fludarabine, and cyclophosphamide (R-FC) in patients with previously untreated chronic lymphocytic leukemia (CLL)
    Hornberger, J. C.
    Reyes, C. M.
    Shewade, A.
    Friedmann, M.
    Chan, L.
    Gutierrez, H.
    Satram-Hoang, S.
    Lerner, S.
    Keating, M. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [35] Fludarabine, Cyclophosphamide and Rituximab (FCR) As First Line Treatment in Patients with Chronic Lymphocytic Leukemia (CLL): A Long-Term Analysis of the German CLL Study Group (GCLLSG) Registry
    Kutsch, Nadine
    Fink, Anna Maria
    Federhen, Anno
    Giza, Adam
    Robrecht, Sandra
    Stumpf, Janina
    Stoltefuss, Andrea
    Vehling-Kaiser, Ursula
    Koenigsmann, Michael
    Tausch, Eugen
    Schneider, Christof
    Stilgenbauer, Stephan
    Illmer, Thomas
    Schlag, Rudolf
    Doerfel, Steffen
    Gaska, Tobias
    Kiehl, Michael G.
    Fischer, Kirsten
    Eichhorst, Barbara
    Hallek, Michael
    BLOOD, 2022, 140 : 9879 - 9881
  • [36] Oral fludarabine and cyclophosphamide in previously untreated chronic lymphocytic leukemia (CLL): Preliminary data.
    Cazin, B
    Binet, JL
    Divine, M
    Lepretre, S
    Lederlin, P
    Travade, P
    Lemaire, G
    Guibon, O
    BLOOD, 2000, 96 (11) : 515A - 515A
  • [37] Combination of fludarabine (FAMP) cyclophosphamide (CTX) and alemtuzumab for patients with relapsed chronic lymphocytic leukemia (CLL).
    Tedeschi, A
    Montillo, M
    Miqueleiz, S
    Draisci, M
    Ricci, F
    Scarpati, B
    Mura, ME
    Crugnola, M
    Morra, E
    BLOOD, 2005, 106 (11) : 341B - 341B
  • [38] First Line Treatment of Chronic Lymphocytic Leukemia (CLL) Patients With Obinutuzumab Based Therapy: Single-Center Experience
    Trajkova, Sanja
    Pivkova-Veljanovska, Aleksandra
    Krstevska-Balkanov, Svetlana
    Popova-Labacevska, Marija
    Ridova, Nevenka
    Stojanovska-Jakimovska, Simona
    Cvetanovski, Milche
    Chadievski, Lazar
    Kocoski, Bozidar
    Panovska-Stavridis, Irina
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S326 - S326
  • [39] EFFICACY AND TOLERANCE OF FLUDARABINE AND CYCLOPHOSPHAMIDE(FC) COMBINATION REGIMEN IN ADVANCE STAGE CHRONIC LYMPHOCYTIC LEUKEMIA
    Alwan, F.
    Matti, F.
    Naji, S.
    Majid, F.
    Sabir, F.
    HAEMATOLOGICA, 2012, 97 : 306 - 306
  • [40] Oral fludarabine and cyclophosphamide plus rituximab in the treatment of the chronic lymphocytic leukemia.
    Casula, P
    Sorano, G
    Pulixi, D
    Culurgioni, F
    Angelucci, E
    BLOOD, 2005, 106 (11) : 341B - 342B
12345